Drug intelligence / Profile preview

hydroxycamptothecin

Development stage
Unknown
Lead developer
Harbin Medisan Pharmaceutical
Modality
Small Molecules
Administration
Intraperitoneal, Intravenous, Intravesical, Parenteral
01

Overview

Hydroxycamptothecin (also known as 10-hydroxycamptothecin or HCPT) is a natural quinoline alkaloid isolated from the Chinese tree *Camptotheca acuminata*. It is a potent antineoplastic agent that acts as a DNA topoisomerase I inhibitor. By stabilizing the covalent topoisomerase I-DNA cleavable complex, hydroxycamptothecin prevents DNA religation, leading to lethal double-strand DNA breaks during replication and transcription, which ultimately triggers cell cycle arrest and apoptosis. In China, hydroxycamptothecin injection is approved for the treatment of various malignancies, including primary liver cancer, gastric cancer, bladder cancer, rectal cancer, and head and neck cancer. Harbin Medisan Pharmaceutical is one of the key manufacturers and developers of this approved formulation.

Brand names
ModiqiTuoxi拓僖默迪奇
Other names
10-HCPT10-hydroxycamptothecin10-hydroxycamptothecineHCPThydroxycamptothecinehydroxylcamptothecinhydroxylcamptothecine
02

Targets

TOP1 (DNA Topoisomerase I)

Beyond the preview

Go deeper on hydroxycamptothecin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hydroxycamptothecin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call